Bruker Expands Microbiology and Infection Diagnostics Portfolio
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
The ADLM honored senator Shelley Moore Capito for advancing pediatric reference intervals, citing her support for related provisions in Senate appropriations bills for FY 2025 and 2026.
The company introduced systems for single-cell proteomics, clinical sample processing, and spatial proteomics.
In studies using National Lung Screening Trial biospecimens, a liquid biopsy assay showed similar sensitivity to low-dose CT screening and detected cancers missed by imaging.